What's Next for Parkinson's Research in 2020? | FoxFlash December 2019

In the Final Days of 2019, MJFF Deploys Another $15 Million in New Research The 46 studies funded by The Michael J. Fox Foundation (MJFF) include a survey to help us better understand cannabis use and effects, several projects around alpha-synuclein, and research into new ways to image disease in the brain. Continue Reading > Eating Well with Parkinson's Disease Hear expert discussion and ask your questions in our Third Thursdays Webinar series. January 16, 2020 at 12 p.m. ET   Here. Until Parkinson's isn’t. With your continued support, we are pursuing every worthy idea. Please keep us on track by giving a gift today toward a future without Parkinson’s disease. Donate Now > Highlighting 2019 Progress and Looking Ahead to 2020 MJFF reflects on the momentum we've built together with patients, families, caregivers, researchers, industry partners and donors in 2019. And, we also look ahead to 2020 with optimism for new opportunities to make Parkinson's history. Download the Booklet > FDA Reviewing New Treatment for "Off" Episodes Sunovion Pharmaceuticals Inc. announced that the FDA accepted its New Drug Application for apomorphine sublingual film. A decision is expected by May 21, 2020. Read More > MJFF Awarded "Excellence in Partnering" from the Centers for Disease Control and Prevention The award recognized the Foundation, the National Multiple Sclerosis Society and other key stakeholders for collaboration across science, communication, policy and evaluation. Find Out More > Free Educational Event for People with Parkinson's and Their Loved Ones Our next Parkinson's IQ + You event is in Phoenix on January 11. Learn about managing PD, building your care team, and the latest research. Not in Arizona? Visit our website for a list of 2020 events around the U.S. Read More and Register >